Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Purespring Therapeutics to present new data on pipeline progress in Alport Syndrome at the American Society of Nephrology (ASN) Kidney Week 2026
-
IP Services Announces Expanded Focus on Executive Cybersecurity and AI Governance Under Scott Alldridge
-
TTM Technologies, Inc. to Conduct Third Quarter 2026 Conference Call on October 22, 2026
-
Form 8.3 - Ramsdens Holdings Plc
-
Calian awarded CAD$47 million contract for NATO Joint Warfare Centre scenario development program
-
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome
-
Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome
-
DMC Global to Report Third Quarter Financial Results on October 27, 2026
-
Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems
-
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise
-
Minuteman Press Franchise Owner Eric Burrill Celebrates 8 Years & Grows Family Business in Avondale Estates, GA
-
OutSolve Releases New Report Examining the Surge in I-9 Enforcement and Its Impact on Employers
-
Why Today’s Affordability Crisis Has Become a Workplace Challenge - New Kashable White Paper
-
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
-
Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients
-
PyroGenesis Receives $860,000 Down Payment for Recently Announced Two-Torch Contract with European Mining, Metallurgy & Materials Client
-
Lux Metals Intersects 17.57 g/t Au over 19.50 m in First Hole at Zone 32, La Grande Gold Project, James Bay, Québec
-
Latest Valoir Research Finds Fear of Messing Up AI Adoption is Eroding HR’s Confidence
-
Yukon Metals Confirms New Copper-Gold-Molybdenum Porphyry-Style System at Viper Prospect, AZ Project
-
NorthWest Intersects 31.4 Metres of 0.92% Copper and 1.08 g/t Gold (2.11% CuEq) at Kwanika in the Pit Zone from 78 Metres
-
Marovi Opens Its Evaluation Intelligence Engine to Executives Exploring Their Next Move
-
Aya Gold & Silver Reports Record Q3-2026 Production of 2.03 Million AgEq Ounces
-
Alpha Compute Signs Binding GPU Contract, Leasing ALPHA-03 cluster under Four-Year, $81.7 Million Agreement in its Missouri Superintelligence Factory
-
Seyond to Showcase Live LiDAR Operational Twin Demo at Dell Technologies and NVIDIA Booth at Smart City Expo World Congress 2026
-
Climb adds Netwrix to its Security Portfolio, Bringing Data and Identity Security to VARs and MSPs
-
Macerich Schedules Third Quarter 2026 Earnings Release and Conference Call
-
Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
-
Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
-
Guns.com Dealer Network Sales Surge Nationwide Heading into the Holiday Season
-
Ridgepost Capital to Announce Third Quarter 2026 Financial Results and Host Investor Call
-
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
-
PyroGenesis Receives $860,000 Down Payment for Recently Announced Two-Torch Contract with European Mining, Metallurgy & Materials Client
-
Peoples, Ltd. Begins Trading on OTCQX Best Market
-
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
-
Eden Project Grows Live Learning with LiveU Technology
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Garrett Motion to Hold Third Quarter 2026 Financial Results Conference Call on Thursday October 29th, 2026
-
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
-
SOPRIS TECHNOLOGIES Appoints Global Technology Executive Hari Haran to Board of Directors
-
Orezone Reports Third Quarter 2026 Production Results
-
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
National Fuel Gas Company Announces Plan to Separate Its Integrated Upstream and Gathering Business
-
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
-
Middle East Stablecoin Association Partners with Luna PR to Shape the Future of Digital Finance in the Region
-
A Review Paid for by the Municipality Found Argyle Conduct Fell Short of the Standard Expected. Residents are Asking Council to Act
-
Harju Elekter Group to divest part of its holding in Skeleton Technologies Group OÜ
-
Himax WiseEye Ultralow Power AI Adopted in Alibaba’s Latest Qwen Glasses
-
GoCharting Receives Dhan's Tech Innovators Award and Is Named One of Dhan's Top Partners of 2026
-
GoCharting Receives Dhan's Tech Innovators Award and Is Named One of Dhan's Top Partners of 2026
-
Landsbankinn hf.: Financial results for Q3 2026 to be published 29 October 2026
